BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Wezenbeek J, Canada JM, Ravindra K, Carbone S, Kadariya D, Trankle CR, Wohlford G, Buckley L, Del Buono MG, Billingsley H, Viscusi M, Tchoukina I, Shah KB, Arena R, Van Tassell B, Abbate A. Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions. Am J Cardiol 2020;125:76-81. [PMID: 31703805 DOI: 10.1016/j.amjcard.2019.09.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Fatrin S, Okwose NC, Bailey K, Velicki L, Popovic D, Ristic A, Seferovic PM, Macgowan GA, Jakovljevic DG. Haemodynamic determinants of quality of life in chronic heart failure. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-022-02829-w] [Reference Citation Analysis]
2 Mihalick V, Wohlford G, Talasaz AH, Ho AJ, Kim F, Canada JM, Carbone S, Kadariya D, Billingsley H, Trankle C, Del Buono MG, Moroni F, Arena R, Abbate A, Van Tassell B. Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure. Am J Cardiol 2022;174:61-7. [PMID: 35473780 DOI: 10.1016/j.amjcard.2022.03.026] [Reference Citation Analysis]
3 Van Tassell B, Mihalick V, Thomas G, Marawan A, Talasaz AH, Lu J, Kang L, Ladd A, Damonte JI, Dixon DL, Markley R, Turlington J, Federmann E, Del Buono MG, Biondi-Zoccai G, Canada JM, Arena R, Abbate A. Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study. J Transl Med 2022;20:270. [PMID: 35706006 DOI: 10.1186/s12967-022-03466-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liao Y, Liu K, Zhu L. Emerging Roles of Inflammasomes in Cardiovascular Diseases. Front Immunol 2022;13:834289. [PMID: 35464402 DOI: 10.3389/fimmu.2022.834289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Canada JM, Park TS, Ravindra K, Chiabrando JG, Del Buono MG, van Wezenbeek J, Trankle CR, Kadariya D, Keen L, Carbone S, Billingsley H, Wohlford GF, Arena R, Van Tassell BW, Abbate A. Comparison of Cardiorespiratory Fitness in Black or African American Versus Caucasian Patients With Heart Failure. J Cardiopulm Rehabil Prev 2022;42:39-44. [PMID: 34793367 DOI: 10.1097/HCR.0000000000000605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Świątkiewicz I, Magielski P, Kubica J. C-Reactive Protein as a Risk Marker for Post-Infarct Heart Failure over a Multi-Year Period. Int J Mol Sci 2021;22:3169. [PMID: 33804661 DOI: 10.3390/ijms22063169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
7 Arena R, Canada JM, Popovic D, Trankle CR, Del Buono MG, Lucas A, Abbate A. Cardiopulmonary exercise testing - refining the clinical perspective by combining assessments. Expert Rev Cardiovasc Ther 2020;18:563-76. [PMID: 32749934 DOI: 10.1080/14779072.2020.1806057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res 2020;126:1260-80. [PMID: 32324502 DOI: 10.1161/CIRCRESAHA.120.315937] [Cited by in Crossref: 205] [Cited by in F6Publishing: 211] [Article Influence: 102.5] [Reference Citation Analysis]